A persistent inflammatory response with cytokine activation or expression of tissue factors is a primary cause of hypercoagulation in various inflammatory or infectious disorders. The inflammatory process and coagulation pathway play significant roles in the body’s response to bacterial infections. D-dimer, a biomarker of fibrin degradation and coagulation, has been linked to the activation of the coagulation system and decreased urinary excretion, which are considered the main causes of elevated serum D-dimer levels in patients with renal disorders (
2,
4). However, all of our study participants had normal GFR, as assessed by serum creatinine.
We found that children with APN had significantly higher WBC, Hgb, and microscopic hematuria compared to those with other bacterial infections. Notably, Hgb > 9.7 g/dL was a reliable predictor of APN, with an acceptable sensitivity of 80%. Additionally, WBC > 13,400/mm³ was found to be an accurate and meaningful variable for predicting acute febrile UTI, though with lower sensitivity and specificity.
Based on the cutoff values, serum D-dimer levels were elevated across all participants with different bacterial febrile infections. However, D-dimer was not a significant differentiating factor for APN compared to other bacterial febrile infections, suggesting it serves as a general acute inflammatory biomarker. Furthermore, the cutoff value of serum D-dimer was higher in cases of APN complicated by VUR than in those without VUR, possibly reflecting a secondary response to bacterial inflammation in VUR.
Similarly, Esteghamati et al. evaluated plasma D-dimer levels in two separate studies, showing increased D-dimer in 16.3% of children with febrile UTI, regardless of the isolated organism. They suggested that serum D-dimer measurement is an appropriate test for diagnosing UTI with low false negative rate (
4). In a subsequent study, they reported a significant positive correlation between serum D-dimer and ESR and CRP, but not with age or gender in children with febrile UTI (
5). In our study, we also found a positive correlation between serum D-dimer and ESR, underscoring D-dimer’s role as an inflammatory marker in bacterial infections.
In the report by Lee et al., the AUC of serum D-dimer was found to be superior to other inflammatory biomarkers, such as WBC and ESR, but inferior to CRP for predicting APN. They observed higher serum D-dimer levels in APN compared to lower UTIs, suggesting D-dimer as an acute-phase inflammatory biomarker in infants with APN. Additionally, they identified it as a significant predictor of VUR (
2). In our study, we also reported elevated serum D-dimer in children with acute febrile UTI, with a higher cutoff in those with VUR.
Mu et al. demonstrated that increased serum D-dimer acts as an independent risk factor for UTI in patients with intracranial hemorrhage, indicating its role as an inflammatory biomarker for UTI (
6). Similarly, Rodelo et al. suggested that D-dimer serves as a prognostic marker in patients with inflammation and septicemia (
3).
Consistent with our findings, Lins et al. reported significantly higher serum D-dimer levels in patients with conditions such as pneumonia, bronchitis, and UTI compared to a healthy control group (
7).
These findings suggest that serum D-dimer functions as an inflammatory biomarker across various bacterial febrile infections, including APN, but lacks specificity as a diagnostic marker for febrile UTI compared to other bacterial infections.
5.1. Conclusions
Serum D-dimer levels increased in children with APN and other bacterial febrile infections in our study. It was identified as a nonspecific inflammatory biomarker for various bacterial infections but not as a reliable diagnostic test for febrile UTI in cases with diagnostic ambiguity. However, due to the relatively small sample size in our study, future research with larger patient groups is recommended to better assess the predictive value of serum D-dimer in children with acute febrile UTI, in comparison to lower UTI and other bacterial infections.